Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of the NLRP3 Inflammasome by Posttranslational Modifications
Safoura Zangiabadi, Ali A. Abdul‐Sater
The Journal of Immunology (2022) Vol. 208, Iss. 2, pp. 286-292
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

How location and cellular signaling combine to activate the NLRP3 inflammasome
Anil Akbal, Alesja Dernst, Marta Lovotti, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1201-1214
Open Access | Times Cited: 122
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants
Shouya Feng, Matthew C Wierzbowski, Katja Hrovat-Schaale, et al.
Nature Immunology (2025)
Open Access | Times Cited: 2
Involvement of Inflammasome Components in Kidney Disease
Ana Karina Aranda‐Rivera, Anjali Srivastava, Alfredo Cruz‐Gregorio, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 246-246
Open Access | Times Cited: 40
Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Qí Zhāng, Xi‐min Hu, Wenjuan Zhao, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 658-674
Open Access | Times Cited: 35
NLRP3 Inflammasome: A key contributor to the inflammation formation
Wen-Juan Zhang, Kejun Li, Lan Yi, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113683-113683
Closed Access | Times Cited: 35
Fantastic voyage: The journey of NLRP3 inflammasome activation
Xiangyong Que, Sihao Zheng, Qibin Song, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 819-829
Open Access | Times Cited: 25
NLRP3 selectively drives IL-1β secretion by Pseudomonas aeruginosa infected neutrophils and regulates corneal disease severity
Martin Minns, Karl Liboro, Tatiane S. Lima, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia
Zhu Liang, Andreas Damianou, Iolanda Vendrell, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114152-114152
Open Access | Times Cited: 9
NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
Chiara Moltrasio, Maurizio Romagnuolo, Angelo Valerio Marzano
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
Jack Jonathan Maran, Moradeke M. Adesina, Colin Green, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101954-101954
Closed Access | Times Cited: 18
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
Ye Tao, Weiyan Tao, Xiaoyi Chen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 1-13
Closed Access | Times Cited: 17
Targeting pyroptosis to treat ischemic stroke: From molecular pathways to treatment strategy
Lina Li, Chonglin Shi, Fang Dong, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112168-112168
Closed Access | Times Cited: 6
DNA Damage and Repair in Migraine: Oxidative Stress and Beyond
Michał Fila, Aleksandra Jabłkowska, Elżbieta Pawłowska, et al.
The Neuroscientist (2022) Vol. 29, Iss. 3, pp. 277-286
Closed Access | Times Cited: 22
Vav1 promotes inflammation and neuronal apoptosis in cerebral ischemia/reperfusion injury by upregulating microglial and NLRP3 inflammasome activation
Jing Qiu, Jun Guo, Liang Liu, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 11, pp. 2436-2442
Open Access | Times Cited: 14
1,8-cineole ameliorates experimental diabetic angiopathy by inhibiting NLRP3 inflammasome-mediated pyroptosis in HUVECs via SIRT2
Jian Zhang, Xinlin Li, Wen-Qing Cui, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117085-117085
Open Access | Times Cited: 5
NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns
Bo Wei, Zachary P. Billman, Kengo Nozaki, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
Pengfei Chen, Xia Li
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
NLRP3 and Gut–Liver Axis: New Possibility for the Treatment of Alcohol‐Associated Liver Disease
Lu Dong, Haotian Zhang, Yoonjin Kang, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
NLRP3 Inflammasome-mediated pyroptosis in acute lung injury: Roles of main lung cell types and therapeutic perspectives
Jing Wang, Lulu Li, Zhen‐Ao Zhao, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114560-114560
Closed Access
PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension
Juan Liao, Shanshan Xie, Yan Deng, et al.
Microvascular Research (2022) Vol. 146, pp. 104471-104471
Open Access | Times Cited: 20
Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
Pritam Thapa, Sunil P. Upadhyay, Vikas Singh, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 7, pp. 100100-100100
Open Access | Times Cited: 19
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases
Mina Dadkhah, Mohammadreza Sharifi
International Reviews of Immunology (2024) Vol. 44, Iss. 2, pp. 98-111
Closed Access | Times Cited: 4
Recent advances in the effects of dietary polyphenols on inflammation in vivo: potential molecular mechanisms, receptor targets, safety issues, and uses of nanodelivery system and polyphenol polymers
Dongxu Wang, Taotao Wang, Zhihong Zhang, et al.
Current Opinion in Food Science (2022) Vol. 48, pp. 100921-100921
Closed Access | Times Cited: 18
A patent review of NLRP3 inhibitors to treat autoimmune diseases
Yiming Xu, Savannah Biby, Baljit Kaur, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 6, pp. 455-470
Closed Access | Times Cited: 10
Cutting Edge: Negative Regulation of Inflammasome Activation by TRAF1 Can Limit Gout
Ali Mirzaesmaeili, Safoura Zangiabadi, Jonathan Raspanti, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 5, pp. 531-535
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top